药品名称NAVANE
申请号016584产品号005
活性成分THIOTHIXENE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格20MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构PFIZER INC
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
016584060APLabel2010/12/04下载
016584060APLetter2010/12/06下载
016584059APLabel2009/07/23下载
016584059APLetter2009/07/23下载
016584058APLetter2008/08/19下载
016584058APLabel2008/08/26下载
016584057APLetter2008/04/10下载
016584057APLabel2008/04/16下载
016584056APLabel2004/06/09下载
016584055APLetter2001/07/31下载
016584047APLetter2001/07/31下载
016584047APLabel2003/06/16下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
016584060AP2010/12/01Labeling Revision
016584059AP2009/07/19Labeling Revision
016584058AP2008/08/14Labeling Revision
016584057AP2008/04/07Labeling Revision
016584056AP2003/05/19Labeling Revision
016584055AP2001/07/31Labeling Revision
016584054AP2001/02/28Manufacturing Change or Addition
016584052AP2000/03/27Package Change
016584051AP1994/07/26Manufacturing Change or Addition
016584047AP2001/07/31Labeling Revision
016584045AP1984/06/26Manufacturing Change or Addition
016584044AP1984/06/21Package Change
016584042AP1982/12/10Expiration Date Change
016584039AP1981/05/21Control Supplement
016584038AP1981/03/10Formulation Revision
016584037AP1982/09/24Formulation Revision
016584036AP1980/12/10Labeling Revision
016584035AP1980/10/08Expiration Date Change
016584034AP1980/09/15Formulation Revision
016584033AP1979/10/03Package Change
016584030AP1978/12/11Formulation Revision
016584029AP1978/12/08Manufacturing Change or Addition
016584028AP1978/07/07Labeling Revision
016584027AP1978/07/07Package Change
016584025AP1977/02/18Formulation Revision
016584023AP1976/07/29Package Change
016584022AP1975/05/01Control Supplement
016584020AP1974/06/24Control Supplement
016584000AP1967/07/24Approval